|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.
There are no as such competitors for Kymera Therapeutics.
The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Berenberg on 2021-04-14. The analyst firm set a price target for 0.00 expecting KYMR to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $44.05 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kymera Therapeutics.
There is no upcoming split for Kymera Therapeutics.